The health benefits of dietary polyphenols on pediatric intestinal diseases: Mechanism of action, clinical evidence and future research progress

Phytother Res. 2024 Jul;38(7):3782-3800. doi: 10.1002/ptr.8218. Epub 2024 Jun 5.

Abstract

Pediatric intestinal development is immature, vulnerable to external influences and produce a variety of intestinal diseases. At present, breakthroughs have been made in the treatment of pediatric intestinal diseases, but there are still many challenges, such as toxic side effects, drug resistance, and the lack of more effective treatments and specific drugs. In recent years, dietary polyphenols derived from plants have become a research hotspot in the treatment of pediatric intestinal diseases due to their outstanding pharmacological activities such, as anti-inflammatory, antibacterial, antioxidant and regulation of intestinal flora. This article reviewed the mechanism of action and clinical evidence of dietary polyphenols in the treatment of pediatric intestinal diseases, and discussed the influence of physiological characteristics of children on the efficacy of polyphenols, and finally prospected the new dosage forms of polyphenols in pediatrics.

Keywords: clinical evidence; intestinal microbes; mechanism of action; natural polyphenols; pediatric intestinal disorders; treatment.

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Child
  • Diet
  • Gastrointestinal Microbiome / drug effects
  • Humans
  • Intestinal Diseases* / diet therapy
  • Intestinal Diseases* / drug therapy
  • Intestinal Diseases* / prevention & control
  • Polyphenols* / pharmacology

Substances

  • Polyphenols
  • Antioxidants
  • Anti-Inflammatory Agents